ConductScience.org, home

Gene · 7051

Papers2,299

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

81 to 100 of 2,299

Download this page as JSON
TitleJournalYearPMIDFound bySource
Mimicking the LOX-Related Autosomal Recessive Congenital Ichthyosis Skin Disease Using a CRISPR-Cas9 System and Unravelling 12S-LOX Function in the Skin.Dermatopathology (Basel)202540981344PubTator, text miningPubMed
Efficacy of Encorelane in Enhancing Barrier Function and Reducing Aging Signs in Sensitive Skin.J Cosmet Dermatol202540952030PubTator, text miningPubMed
Transglutaminase-catalyzed glycosylation of egg white peptides: Structural modulation and molecular mechanism of umami enhancement via T1R1/T1R3 interactions.Food Res Int202540922226PubTator, text miningPubMed
Characterization of Whey Protein Isolate-Soymilk Complexes Modified by Transglutaminase and Their Application inYuba Film.Foods202540870828PubTator, text miningPubMed
Examples of Underexploited Marine Organisms in Cosmeceutical Applications.Mar Drugs202540863622PubTator, text miningPubMed
Bathing suit ichthyosis: a case report of a 13-year-old boy with unique clinical features and genetic insights from Syria.Ann Med Surg (Lond)202540851976PubTator, text miningPubMed
Potential and Challenges of a Targeted Membrane Pre-Fouling: Process Performance of Milk Protein Fractionation After the Application of a Transglutaminase Treatment of Casein Micelles.Foods202540807618PubTator, text miningPubMed
Sustained release of cathepsin D/cathepsin K from injectable hydrogel microspheres in anti-photoaging.Mater Today Bio202540799995PubTator, text miningPubMed
Role of homovanillic acid esters in the regulation of skin inflammatory pathways and their effect on tight junction protein expression.Front Pharmacol202540761393PubTator, text miningPubMed
Skin Barrier Dysfunction in Chronic Dermatoses: From Pathophysiology to Emerging Therapeutic Strategies.Cureus202540734872PubTator, text miningPubMed
Effects of EGCG/TGase on the physicochemical properties and in vitro dynamic digestion characteristics of water-saving rinsed surimi gels.Food Chem202540729995PubTator, text miningPubMed
Curdlan-Induced Significant Enhancement of Lipid Oxidation Control and Gelling Properties of Low-Salt Marine Surimi Gel Containing Transglutaminase and Lysine.Gels202540710697PubTator, text miningPubMed
Metabolites profile and endogenous enzymes changes in pre-dehydrated surimi: Mechanistic insights into gelling properties and flavor characteristics.Food Res Int202540597464PubTator, text miningPubMed
Effect of TGase Crosslinking on the Structure, Emulsification, and Gelling Properties of Soy Isolate Proteins.Foods202540565739PubTator, text miningPubMed
Induced Pluripotent (iPSC) and Mesenchymal (MSC) Stem Cells for In Vitro Disease Modeling and Regenerative Medicine.Int J Mol Sci202540565081PubTator, text miningPubMed
Insights into the synergistic cross-linking effect of EGCG and TGase on surimi gels.Food Chem202540561757PubTator, text miningPubMed
Retraction notice to "Localization of the TIG3 Transglutaminase Interaction Domain and Demonstration that the Amino-Terminal Region Is Required for TIG3 Function as a Keratinocyte Differentiation Regulator" [Journal of Investigative Dermatology, Volume 128, March 2008, Pages 517-529].
J Invest Dermatol202540409913Swiss-Prot, curatedPubMed
Improvement of transglutaminase production by controlling the morphology of Streptomyces mobaraensis HVCP-Sm1 with microparticle-enhanced cultivation.Biotechnol Lett202540381072PubTator, text miningPubMed
Accelerating ion transport in polycrystalline conductors: On pores and grain boundaries.Sci Adv202540367157PubTator, text miningPubMed
Effect of cation type on the formation, structure and functional properties of enzyme-crosslinked pea protein gels and emulsion gels.Food Chem202540359795PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/7051/papers?page=5